Abstract
Stroke is a leading cause of death and disability worldwide. Conventional treatment has a limitation of very narrow therapeutic time window and its devastating nature necessitate a novel regenerative approach. Transplanted stem cells resulted in functional recovery through multiple mechanisms including neuroprotection, neurogenesis, angiogenesis, immunomodulation, and anti-inflammatory effects. Despite the promising features shown in experimental studies, results from clinical trials are inconclusive from the perspective of efficacy. The present review presents a synopsis of stem cell research on ischemic stroke treatment according to cell type. Clinical trials to the present are briefly summarized. Finally, the hurdles and issues to be solved are discussed for clinical application.
Keywords: Stroke, cell-based therapy, clinical trials, stem cells, angiogenesis, immunomodulation.
Current Pharmaceutical Design
Title:Current Perspectives Regarding Stem Cell-based Therapy for Ischemic Stroke
Volume: 24 Issue: 28
Author(s): Kyeong-Ah Kwak, Ho-Beom Kwon, Joo Won Lee and Young-Seok Park*
Affiliation:
- Department of Oral Anatomy, Seoul National University School of Dentistry and Dental Research Institute, Seoul, 101 Daehakro, Jongno-Gu, Seoul, 03080,Korea
Keywords: Stroke, cell-based therapy, clinical trials, stem cells, angiogenesis, immunomodulation.
Abstract: Stroke is a leading cause of death and disability worldwide. Conventional treatment has a limitation of very narrow therapeutic time window and its devastating nature necessitate a novel regenerative approach. Transplanted stem cells resulted in functional recovery through multiple mechanisms including neuroprotection, neurogenesis, angiogenesis, immunomodulation, and anti-inflammatory effects. Despite the promising features shown in experimental studies, results from clinical trials are inconclusive from the perspective of efficacy. The present review presents a synopsis of stem cell research on ischemic stroke treatment according to cell type. Clinical trials to the present are briefly summarized. Finally, the hurdles and issues to be solved are discussed for clinical application.
Export Options
About this article
Cite this article as:
Kwak Kyeong-Ah , Kwon Ho-Beom , Lee Won Joo and Park Young-Seok*, Current Perspectives Regarding Stem Cell-based Therapy for Ischemic Stroke, Current Pharmaceutical Design 2018; 24 (28) . https://dx.doi.org/10.2174/1381612824666180604111806
DOI https://dx.doi.org/10.2174/1381612824666180604111806 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Microwave Assisted Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review
Current Cardiology Reviews Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach
Cardiovascular & Hematological Disorders-Drug Targets Non-Invasive Methods and Techniques for Central Blood Pressure Estimation: Procedures, Validation, Reproducibility and Limitations
Current Pharmaceutical Design The Effects of Dietary Supplements that Overactivate the Nrf2/ARE System
Current Medicinal Chemistry Potassium Channels as Targets for the Management of Pain
Central Nervous System Agents in Medicinal Chemistry Empyema and Bronchopleural Fistula Following Lung Resection
Current Respiratory Medicine Reviews Patent Selections
Recent Patents on Biomarkers Crucial Protein Based Drug Targets and Potential Inhibitors for Osteoporosis: New Hope and Possibilities
Current Drug Targets Application of Diet-derived Taste Active Components for Clinical Nutrition: Perspectives from Ancient AyurvedicMedical Science, Space Medicine, and Modern Clinical Nutrition
Current Pharmaceutical Design Effects of Estrogen in Gender-dependent Fetal Programming of Adult Cardiovascular Dysfunction
Current Vascular Pharmacology PEGylation: a successful approach to improve the biopharmaceutical potential of snake venom thrombin-like serine protease
Protein & Peptide Letters Achieving Better Blood Pressure Control in High-Risk Patients with Type 2 Diabetes Using Combination Antihypertensive Therapy
Vascular Disease Prevention (Discontinued) Towards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium Channels
Current Molecular Pharmacology Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Insights into Targeting NEMO for Pharmacological Regulation
Current Drug Targets The Biochemical and Physical Process of Fibrinolysis and Effects of Clot Structure and Stability on the Lysis Rate
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacokinetics/Pharmacodynamics Model-Supported Early Drug Development
Current Pharmaceutical Biotechnology Recent Progress in the Analysis of Captopril Using Electrochemical Methods: A Review
Current Analytical Chemistry Treatment Strategies Against Diabetic Foot Ulcer: Success so Far and the Road Ahead
Current Diabetes Reviews